Overview Financials News + Filings Key Docs Ownership Insiders
|
Dermata Therapeutics, Inc.
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Source | Source | Source |
Turnover Ratios |
Asset turnover | 0.0 | 0.0 | |
|
Returns on Capital |
ROIC (including intangibles) | 5177.1% | 101.5% | 0.0% |
ROE | -77.7% | 99.8% | 0.0% |
ROA | -67.6% | -524.0% | 0.0% |
|
Cash Conversion Cycle |
Days sales outstanding | 0.0 | | 0.0 |
Days payables outstanding | 1,042.3 | | 27,529,177.2 |
Cash conversion cycle | -1,042.3 | | -27,529,177.2 |
|